Use of 68Ga-dotatate PET Scan in Neuroendocrine Carcinoma of the GI Tract
Condition(s):Neuroendocrine CarcinomaLast Updated:March 21, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):Neuroendocrine CarcinomaLast Updated:March 21, 2024Recruiting
Condition(s):Carcinoid Heart Disease; Carcinoid Syndrome; Carcinoid TumorLast Updated:August 4, 2020Not yet recruiting
Condition(s):NeuroblastomaLast Updated:February 14, 2024Recruiting
Condition(s):Neuroendocrine Tumors; Pheochromocytoma; ParagangliomaLast Updated:June 8, 2021Withdrawn
Condition(s):Cardiac SarcoidosisLast Updated:December 14, 2022Completed
Condition(s):Endocarditis; ThrombosisLast Updated:August 26, 2021Terminated
Condition(s):Prostate CancerLast Updated:July 26, 2021Completed
Condition(s):Neuroblastoma Recurrent; NeuroblastomaLast Updated:March 12, 2024Recruiting
Condition(s):Metastatic Nasopharyngeal CancerLast Updated:October 11, 2023Recruiting
Condition(s):Prostatic NeoplasmLast Updated:January 11, 2022Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.